These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 9541038)
41. Moclobemide versus clomipramine in the treatment of depression: a multicentre trial in Spain. Civeira J; Cervera S; Giner J; Allen SR; Hellstern K; Malanowski H; Wirz R; Klar K Acta Psychiatr Scand Suppl; 1990; 360():48-9. PubMed ID: 2248070 [TBL] [Abstract][Full Text] [Related]
42. Serotonin syndrome in the elderly after antidepressive monotherapy. Fischer P J Clin Psychopharmacol; 1995 Dec; 15(6):440-2. PubMed ID: 8748434 [No Abstract] [Full Text] [Related]
43. [Monoamine oxidase inhibitors: poisoning and interactions]. Kooy A; Peters-Romeyn BM; van Gool AR Ned Tijdschr Geneeskd; 1993 Sep; 137(38):1910-4. PubMed ID: 8413691 [No Abstract] [Full Text] [Related]
44. Moclobemide. An update of its pharmacological properties and therapeutic use. Fulton B; Benfield P Drugs; 1996 Sep; 52(3):450-74. PubMed ID: 8875133 [TBL] [Abstract][Full Text] [Related]
45. Evaluation and comparison of the interaction between alcohol and moclobemide or clomipramine in healthy subjects. Berlin I; Cournot A; Zimmer R; Pedarriosse AM; Manfredi R; Molinier P; Puech AJ Psychopharmacology (Berl); 1990; 100(1):40-5. PubMed ID: 2296627 [TBL] [Abstract][Full Text] [Related]
46. [The serotoninergic syndrome: moclobemide and citalopram]. Gumà M; Clemente F; Segura A; Costa J Med Clin (Barc); 1999 Nov; 113(17):677-8. PubMed ID: 10618787 [No Abstract] [Full Text] [Related]
47. Moclobemide versus clomipramine in the treatment of depression: a double-blind multicentre study in Belgium. Dierick M; Cattiez P; Franck G; Burton P; Defleur J; Hermans W; Roelandts A; Wolfrum C; Berger M; Hellstern K Acta Psychiatr Scand Suppl; 1990; 360():50-1. PubMed ID: 2248071 [TBL] [Abstract][Full Text] [Related]
48. Moclobemide and clomipramine in the treatment of depression. A randomized clinical trial. Larsen JK; Holm P; Mikkelsen PL Acta Psychiatr Scand; 1984 Sep; 70(3):254-60. PubMed ID: 6388247 [TBL] [Abstract][Full Text] [Related]
50. Drug interactions of clinical significance with selective serotonin reuptake inhibitors. Mitchell PB Drug Saf; 1997 Dec; 17(6):390-406. PubMed ID: 9429838 [TBL] [Abstract][Full Text] [Related]
51. Successful treatment of serotonin syndrome with chlorpromazine. Gillman PK Med J Aust; 1996 Sep; 165(6):345-6. PubMed ID: 8862337 [No Abstract] [Full Text] [Related]
52. Safety and tolerability of combined treatment with moclobemide and SSRIs: a systematic study of 50 patients. Hawley CJ; Quick SJ; Ratnam S; Pattinson HA; McPhee S Int Clin Psychopharmacol; 1996 Sep; 11(3):187-91. PubMed ID: 8923097 [TBL] [Abstract][Full Text] [Related]
54. Immediate switching from moclobemide to duloxetine may induce serotonin syndrome. Jimenez-Genchi A J Clin Psychiatry; 2006 Nov; 67(11):1821-2. PubMed ID: 17196070 [No Abstract] [Full Text] [Related]
55. Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective serotonin reuptake inhibitors in elderly depressed patients: a clinical overview. Amrein R; Stabl M; Henauer S; Affolter E; Jonkanski I Can J Psychiatry; 1997 Dec; 42(10):1043-50. PubMed ID: 9469236 [TBL] [Abstract][Full Text] [Related]
56. A fatality due to moclobemide. Camaris C; Little D J Forensic Sci; 1997 Sep; 42(5):954-5. PubMed ID: 9304853 [TBL] [Abstract][Full Text] [Related]
57. [Serotonin syndrome. Several cases of this often overlooked diagnosis]. Höjer J; Personne M; Skagius AS; Hansson O Lakartidningen; 2002 May; 99(18):2054-5, 2058-60. PubMed ID: 12082784 [TBL] [Abstract][Full Text] [Related]
58. RIMA--a new concept in the treatment of depression with moclobemide. Amrein R; Hetzel W; Stabl M; Schmid-Burgk W Int Clin Psychopharmacol; 1993 Jan; 7(3-4):123-32. PubMed ID: 8468432 [TBL] [Abstract][Full Text] [Related]
59. Clinical efficacy of reversible and selective inhibitors of monoamine oxidase A in major depression. Paykel ES Acta Psychiatr Scand Suppl; 1995; 386():22-7. PubMed ID: 7717091 [TBL] [Abstract][Full Text] [Related]
60. Moclobemide: a reversible MAO-A-inhibitor showing weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group. J Affect Disord; 1993 Jun; 28(2):105-16. PubMed ID: 8354766 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]